Outcomes at 30 days
| All patients | Bivalirudin | GPI + heparin | p value | |
| No. of patients | 968 | 882 | 85 | |
| Death | 52 (5.4%) | 46 (5.2%) | 6 (7.1%) | 0.450 |
| Cardiac death | 45 (4.7%) | 39 (4.4%) | 6 (7.1%) | 0.277 |
| Re-infarction | 16 (1.7%) | 14 (1.6%) | 2 (2.4%) | 0.645 |
| Unplanned TVR | 12 (1.2%) | 10 (1.1%) | 2 (2.4%) | 0.286 |
| Stroke | 56 (5.8%) | 54 (6.1%) | 2 (2.4%) | 0.222 |
| Death, re-infarction, stroke or TVR | 110 (11.4%) | 100 (11.3%) | 10 (11.8%) | 0.906 |
| Acute stent thrombosis | 10 (1.0%) | 9 (1.0%) | 1 (1.2%) | 0.604 |
| Subacute stent thrombosis | 15 (1.6%) | 13 (1.5%) | 2 (2.4%) | 0.386 |